Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy
A 1-Year Follow-Up Study Published in the Peer-Reviewed Journal Stroke Validates Effectiveness of Paired Vagus Nerve Stimulation Therapy for Improved Upper Limb Function
MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® Paired VNS™ System for chronic stroke recovery, announced the publication of new findings in the peer reviewed medical journal Stroke validating the beneficial long-term outcomes of Paired VNS™ Therapy. The findings demonstrate that stroke survivors treated with paired vagus nerve stimulation (VNS) for upper extremity deficits post-stroke had improvements in impairment, activity, participation and quality of life for at least one year after completing therapy.